Identity, Handling, And Regulation — Research Overview

By Editorial Desk · published 2026-07-04 · last reviewed 2026-07-30 · Guide

This is a working overview of REV-ERB agonist, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-07-30 and is reviewed periodically as new material appears.

Identity, Handling, and Regulation

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Analytical Detection and Stability

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Sr9009 at a glance

Background and Mechanism of SR9009

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

Related pages on this site

• Balanced handbook
• Sustainable workbook
• Scalable digest
• Optimized workbook
• Optimized primer
• Durable update
• Scalable notes
• Focused trends

SR9009 Background and Receptor Mechanism

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

Notes from published material

==== Labour and Employment, 2026-2028 ==== Lad is Inducted as Labour and Employment Minister of DK Shivakumar's Cabinet after reconstitution of Karnataka in 2026. He is also entrusted with responsibility of overseeing Dharwad District as In charge Minister.

=== History === The Local Government Act 1888 reformed English local government by creating administrative counties, county boroughs, and elected county councils and county borough councils to govern them. County boroughs largely consisted of those settlements with a population over 50,000, and administrative counties covered smaller towns and rural areas. The three ridings of Yorkshire were reconstituted as the administrative counties of County of York, East Riding, County of York, North Riding, and County of York, West Riding. Within what would later become West Yorkshire, Bradford, Halifax, Huddersfield, and Leeds were made county boroughs. The Local Government Act 1972, which came into effect in 1974, reformed English local government again. It introduced metropolitan counties, which covered the largest urban areas, and non-metropolitan counties elsewhere. The metropolitan county of West Yorkshire was created from the central part of the West Riding and divided into five metropolitan boroughs. The provision of local government services was divided between West Yorkshire County Council and the district councils of the five boroughs. In Local Government Act 1985, which came into effect the following year, abolished the county council and transferred many of its powers and responsibilities the borough councils. It also created or allowed to be created joint bodies, notably the West Yorkshire Passenger Transport Executive, in which all the borough councils participated.

Although Tg2576 mice do not perfectly replicate late-stage AD with cell death, they do offer a platform for researching the physiology and biochemistry of the illness. With the help of transgenic mouse models, researchers can make progress in AD research by understanding the intricate relationships between gene products that are involved in the production of Aβ peptide.e physiology and biochemistry of the illness.

The most recognizable contributions of the Stalinist period may be the so-called Seven Sisters, seven large skyscrapers distributed around the city at approximately equal distances from the Kremlin. A defining feature of Moscow's skyline, their imposing form was allegedly inspired by the Manhattan Municipal Building in New York City; their style—with intricate exteriors and a large central spire—has been described as Stalinist Gothic architecture. All seven towers can be seen from most elevated locations in the city. These towers are among the tallest constructions in central Moscow apart from the Ostankino Tower; when this tower was completed in 1967, it was the highest freestanding land structure in the world. It remains the world's seventy-second tallest, ranked among buildings such as the Burj Khalifa in Dubai, Taipei 101 in Taiwan, and the CN Tower in Toronto. The Soviet goal of providing housing for every family, along with the rapid growth of Moscow's population, led to the construction of large, monotonous housing blocks. Most of these were built after Stalin's era, and their styles are often named after the contemporary leader (e.g., Brezhnev and Khrushchev). These blocks are usually badly maintained. Although the city retains some five-story apartment buildings constructed before the mid-1960s, more recent apartment buildings are usually at least nine stories tall and have elevators. Moscow is estimated to have more than twice as many elevators as New York City and four times as many as Chicago.

Sources: en.wikipedia.org

Background from the literature

Human MHC class I and II are also called human leukocyte antigen (HLA). To clarify the usage, some of the biomedical literature uses HLA to refer specifically to the HLA protein molecules and reserves MHC for the region of the genome that encodes for this molecule, but this is not a consistent convention. The most studied HLA genes are the nine classical MHC genes: HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRA, and HLA-DRB1. In humans, the MHC gene cluster is divided into three regions: classes I, II, and III. The A, B and C genes belong to MHC class I, whereas the six D genes belong to class II. MHC alleles are expressed in codominant fashion. This means the alleles (variants) inherited from both parents are expressed equally:

== Precautions and contraindications == Administration of tylosin should be avoided in animals with a known hypersensitivity to the product, or to other macrolides. Oral administration can result in diarrhoea and gastrointestinal disturbance. This is particularly true of horses, such that it can be fatal. Tylosin also has a foul taste that is difficult to disguise. The injectable formulations of tylosin can cause pain, inflammation, and itchiness around the injection site. Since tylosin has a relatively poor spectrum of activity against Gram-negative organisms, it may not be a sensible therapeutic choice in the treatment of infections caused by unknown, potentially unsusceptible organisms.

Aceclidine is a parasympathomimetic cholinergic drug that functions as a muscarinic acetylcholine receptor agonist. It is used in ophthalmology as a miotic agent to constrict the pupil. Historically used in Europe for the treatment of glaucoma, aceclidine received its first U.S. approval in 2025 under the brand name Vizz as a topical eye drop for the correction of presbyopia. Its mechanism of action produces pupil contraction with a relatively minimal effect on the ciliary muscle, which improves near visual acuity through a "pinhole" depth-of-field effect without inducing significant accommodative spasm.

On the other hand, external rectal prolapse is reported to be fairly rare, occurring in less than 0.5% of the population. Biomechanics of the rectal wall were found to be abnormal in external rectal prolapse, but normal in IRP, as long as SRUS was not also present. In those patients with both IRP and solitary rectal ulcer syndrome, the inflammation and fibrosis that was detected in the rectal wall was theorized to be due to solitary rectal ulcer syndrome. These findings suggest that IRP and external rectal prolapse are separate, physiologically distinct entities. However, the authors did not rule out the possibility that IRP and external rectal prolapse are different stags of the same disease process. Some researchers said that the possibility that IRP and external rectal prolapse are different, unrelated pathologies is unlikely. They reasoned that patients with IRP and external rectal prolapse share similar features like exaggerated pouch of Douglas, anteriorly excavated pelvis, a narrow rectum which meanders on the pelvic floor, and redundant sigmoid colon. According to this theory, external rectal prolapse would suddenly appear without any prior stage of lesser prolapse.

In the early years of using the technique, it was understood that it depended on the atmospheric 14C/12C ratio having remained the same over the preceding few thousand years. To verify the accuracy of the method, several artefacts that were datable by other techniques were tested; the results of the testing were in reasonable agreement with the true ages of the objects. Over time, however, discrepancies began to appear between the known chronology for the oldest Egyptian dynasties and the radiocarbon dates of Egyptian artefacts. Neither the pre-existing Egyptian chronology nor the new radiocarbon dating method could be assumed to be accurate, but a third possibility was that the 14C/12C ratio had changed over time. The question was resolved by the study of tree rings: comparison of overlapping series of tree rings allowed the construction of a continuous sequence of tree-ring data that spanned 8,000 years. (Since that time the tree-ring data series has been extended to 13,900 years.) In the 1960s, Hans Suess was able to use the tree-ring sequence to show that the dates derived from radiocarbon were consistent with the dates assigned by Egyptologists. This was possible because although annual plants, such as corn, have a 14C/12C ratio that reflects the atmospheric ratio at the time they were growing, trees only add material to their outermost tree ring in any given year, while the inner tree rings don't get their 14C replenished and instead start losing 14C through decay. Hence each ring preserves a record of the atmospheric 14C/12C ratio of the year it grew in.

Sources: en.wikipedia.org

Reference notes

== Biosimilars == In December 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Kixelle, intended for the treatment of diabetes. The applicant for this medicinal product is Mylan IRE Healthcare Limited. Kixelle was approved for medical use in the European Union in February 2021. Kixelle was renamed to Kirsty. Trurapi was approved for medical use in Canada in October 2020. Truvelog and Truvelog Solostar were approved for medical use in Australia in October 2020. In October 2021, Kirsty was approved for medical use in Canada. In February 2022, the CHMP adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Truvelog Mix 30, intended for the treatment of diabetes. The applicant for this medicinal product is sanofi-aventis groupe. It was approved for medical use in the European Union in April 2022. In January 2024, the European Commission withdrew the marketing authorization for Truvelog Mix 30 (insulin aspart) in the European Union. The withdrawal was at the request of the marketing authorization holder, Sanofi Winthrop Industrie, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons. In February 2025, insulin aspart-szjj, sold under the brand names Merilog and Merilog Solostar, is a biosimilar to Novolog that was approved for medical use in the United States in February 2025.

Because the journalists had taken to my press secretary, Dmitry Peskov, and he came to me and, with reference to them, the witnesses of events taking place there, informed of hostilities," he said. It was also stressed by Putin that three days passed before the decision to send troops to South Ossetia was taken, since the decision to use force "is a difficult thing". Putin said that the intense fighting began on 6 August 2008. However, Putin refused to reveal if he pushed for the use of force in August 2008. Putin's statement about his phone talks with Medvedev after the outbreak of large-scale hostilities contradicted Medvedev's 2011 statement that he had no phone talks with Putin and they had contact only the next day. The Georgian Foreign Ministry commented that Putin's statement on Russia having a plan since 2006 contradicted Russia's earlier claims that Russia acted in response to Georgia's "surprise attack" to prevent a "genocide" and to defend Russian citizens. Russian analyst Boris Vadimovich Sokolov commented that Putin's testimony meant that the Russian peacekeepers trained the South Ossettian militias in violation of their mandate and that Russian invasion troops and hardware had entered South Ossetia before 8 August 2008. In June 2013, Russian president Vladimir Putin said in a television interview that Russia attacked Georgia because the Georgian government was smuggling terrorists across Abkhazia to the Russian border near Sochi.

their intensive labouring demands and time consumption their confinements by the definition of the term defined by different standards. To solve this kind of difficulty, some regulatory bodies or methods provide advice on when performing of a specified system suitability test should be applied and compulsory.

=== Contactless atmospheric pressure ionization === Contactless atmospheric pressure ionization is a technique used for analysis of liquid and solid samples by mass spectrometry. Contactless API can be operated without an additional electric power supply (supplying voltage to the source emitter), gas supply, or syringe pump. Thus, the technique provides a facile means for analyzing chemical compounds by mass spectrometry at atmospheric pressure.

Sources: en.wikipedia.org

Frequently asked questions